Clindex
Hopkins
About Clindex
Fortress Medical Systems was founded in 1997 with the launch of Clindex®, the first integrated clinical trial software system designed specifically for medical device trials. Over the years, Clindex® has been used to support not only medical device studies, but also pharmaceutical, diagnostic and combination product studies. By working closely with their customers, they have expanded the functionality of Clindex® so it is one of the most flexible and comprehensive systems on the market today. Their client base spans the world. As a testament to the scalability of Clindex®, their clients range from Fortune 500 corporations to small, start-up companies and include many contract Clinical Research Organizations (CROs) as well. Clindex® has been used in hundreds of studies, a large majority of which were to support marketing applications to the FDA. Clindex® EDC has been deployed worldwide with investigational sites spanning the globe. The FDA has audited studies conducted with Clindex® and to their knowledge no finding or deficiency has ever been attributed to Clindex®.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: fortressmedical.com
- Phone: (+1) 952 238 9010
Social Profiles
Canonical: https://fsome.com/organization/clindex-425316 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.